Home IV Antibiotic Therapy and Exercise Capacity in Children with CF: A Case Series
- PMID: 21448344
- PMCID: PMC3056840
Home IV Antibiotic Therapy and Exercise Capacity in Children with CF: A Case Series
Abstract
Purpose: This case series describes the effect of home intravenous (IV) antibiotic therapy on spirometry and exercise capacity in a group of children with cystic fibrosis (CF).
Methods: Outcomes from 10 children with CF who were prescribed a 14-day course of home IV antibiotics for a respiratory exacerbation are reported. All children performed spirometry and a modified shuttle test (MST) before and after 14-days of home IV therapy.
Results: After 14 days, FEV(1) increased by mean (± SE) 12 ± 4 % (p < 0.05) but mean MST did not improve compared to baseline. All children improved or maintained spirometry values with treatment, however, only 5 improved MST distance.
Conclusion: After 14 days of home IV antibiotic therapy, a significant improvement in spirometry, but not exercise capacity, was seen in this small series of children with CF. The lack of improvement in exercise capacity for all children following home IV antibiotic therapy suggests factors other than spirometry determine exercise capacity. Identifying and investigating the factors that influence exercise capacity during home IV antibiotic therapy requires further investigation.
Keywords: FEV1; Modified Shuttle Test; cystic fibrosis; home IV therapy.
Figures
Similar articles
-
Effects of a supervised, outpatient exercise and physiotherapy programme in children with cystic fibrosis.Pediatr Pulmonol. 2012 Dec;47(12):1235-41. doi: 10.1002/ppul.22587. Epub 2012 May 2. Pediatr Pulmonol. 2012. PMID: 22553169
-
Modified shuttle test performance in hospitalized children and adolescents with cystic fibrosis.J Cyst Fibros. 2006 Aug;5(3):165-70. doi: 10.1016/j.jcf.2006.02.004. Epub 2006 May 5. J Cyst Fibros. 2006. PMID: 16679070
-
Reliability, repeatability, and sensitivity of the modified shuttle test in adult cystic fibrosis.Chest. 2000 Jun;117(6):1666-71. doi: 10.1378/chest.117.6.1666. Chest. 2000. PMID: 10858400
-
Prediction of peak oxygen uptake using the modified shuttle test in children and adolescents with cystic fibrosis.Pediatr Pulmonol. 2019 Apr;54(4):386-392. doi: 10.1002/ppul.24237. Epub 2019 Jan 6. Pediatr Pulmonol. 2019. PMID: 30614221
-
Antibiotic Therapy for Pulmonary Exacerbations in Cystic Fibrosis-A Single-Centre Prospective Observational Study.Antibiotics (Basel). 2023 Apr 9;12(4):734. doi: 10.3390/antibiotics12040734. Antibiotics (Basel). 2023. PMID: 37107096 Free PMC article.
Cited by
-
Clinimetric properties of field exercise tests in cystic fibrosis: a systematic review.Eur Respir Rev. 2024 Dec 18;33(174):240142. doi: 10.1183/16000617.0142-2024. Print 2024 Oct. Eur Respir Rev. 2024. PMID: 39694588 Free PMC article.
References
-
- Rubin BK. Emerging therapies for cystic fibrosis lung disease. Chest. 1999;115:1120–1126. - PubMed
-
- Smith AL. Antibiotic therapy in cystic fibrosis: Evaluation of clinical trials. J Pediatr. 1986;108(2):866–870. - PubMed
-
- Asensio O, Bosque M, Marco T, de Gracia J, Serra C. Home intravenous antibiotics for cystic fibrosis (Review). Cochrane DB Syst Rev. 2000, Issue 4. Art. No.: CD001917. - PubMed
-
- Orenstein DM, Nixon PA, Ross EA, Kaplan RM. The quality of well-being in cystic fibrosis. Chest. 1989;95:344–347. - PubMed
-
- Nixon PA, Orentsein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med. 1992;327:1785–1788. - PubMed
LinkOut - more resources
Full Text Sources